Abdullah Doğan

2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary

Association Between C-Reactive Protein and Recurrence of Atrial Fibrillation After Successful Electrical Cardioversion

Antiarrhythmic Effect of Statin Therapy and Atrial Fibrillation

A Clinical Prediction Model to Estimate Risk for 30-Day Adverse Events in Emergency Department Patients With Symptomatic Atrial Fibrillation

Fish Oil and Postoperative Atrial Fibrillation

Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation

Omega-3 Fatty Acids for the Prevention of Recurrent Symptomatic Atrial Fibrillation

Statin use and development of atrial fibrillation: A systematic review and meta-analysis of randomized clinical trials and observational studies

The role of antioxidants in the chemistry of oxidative stress: A review

Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation

Prevention of Postoperative Atrial Fibrillation: Novel and Safe Strategy Based on the Modulation of the Antioxidant System

Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults

Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention

First-Trimester Prediction of Preeclampsia in Nulliparous Women at Low Risk

Antiarrhythmic Drugs for Maintaining Sinus Rhythm After Cardioversion of Atrial Fibrillation

Prospective study of interleukin-6 and the risk of malignant ventricular tachyarrhythmia in ICD-recipients—A pilot study

Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited

Lipid Peroxidation in Atherosclerotic Cardiovascular Diseases

2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association

Guidelines for the Early Management of Patients With Acute Ischemic Stroke

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation

The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies

Worldwide Epidemiology of Atrial Fibrillation

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Hypertensive Disorders of Pregnancy

Routine echocardiography in the management of stroke and transient ischaemic attack: a systematic review and economic evaluation

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives

Effect of Atorvastatin on the Recurrence Rates of Atrial Fibrillation After Electrical Cardioversion

P-wave dispersion for predicting maintenance of sinus rhythm after cardioversion of atrial fibrillation

Oxidative Stress Status Increase in Patients with Nonischemic Heart Failure

Inflammatory markers according to types of atrial fibrillation

P Wave Dispersion and Left Atrial Appendage Function for Predicting Recurrence after Conversion of Atrial Fibrillation and Relation of P Wave Dispersion to Appendage Function

Mean platelet volume is associated with insulin resistance in non-obese, non-diabetic patients with coronary artery disease

N-3 polyunsaturated fatty acids administration does not reduce the recurrence rates of atrial fibrillation and inflammation after electrical cardioversion: a prospective randomized study

Efficacy of propafenone for maintaining sinus rhythm in patients with recent onset or persistent atrial fibrillation after conversion